Abstract
The 2011 eosinophilic esophagitis (EoE) consensus recommendations recognized the need for further research regarding consequences of prolonged use of swallowed topical steroids (STS), including adrenal suppression.1 Guidelines published in 2017 from the United European Gastroenterology (UEG), the European Academy of Allergy and Clinical Immunology (EAACI), the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), and the European Society of Eosinophilic Oesophagitis (EUREOS) recommend monitoring for adrenal insufficiency for children with EoE in the setting of high doses of STS for long periods, or concomitant use of other corticosteroids for atopic diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Allergy and Clinical Immunology: In Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
